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ABSTRACT Platelet aggregation has previously been shown to occur within 1 s of activation with 100 ,uM adenosine diphosphate
(ADP) for both large (L) and small (S) platelet subpopulations, but L platelets were about twofold more sensitive and more rapidly
recruited into microaggregates than were S platelets after correcting for differences in platelet surface area. Because platelet
aggregation normally requires fibrinogen binding to glycoprotein llb-lIla receptors (FbR) expressed on the activated platelet surface,
we wished to compare the kinetics and nature of FbR expression induced by ADP for L versus S platelets, and to measure
size-dependent differences in FbR expression for platelets maximally activated with phorbol myristate acetate (PMA). We
presented the theory and methodology in Part I (Frojmovic, M., T. Wong, and T. van de Ven. 1991. Biophys. J. 59:815-827) for
measuring the rate of FbR expression (k1) and both the rate (k2) and efficiency (a) of binding of PAC1 to FbR as a function of
activation conditions from the initial on-rate of FITC-PAC1 to FbR (V) and the maximal number of FbR expressed: these are
measured, respectively, from the initial rate of increase in platelet-bound fluorescence (v) and the maximal increase in mean
fluorescence (Fl,.). We extended these analyses to L and S platelets, selected by electronic gating of forward scatter profiles
(FSC), with corresponding fluorescence (Fl) histograms retrieved analytically. Platelet size (V) and surface area (SA), determined
directly for cells separated with a cell sorter, were highly correlated with FSC, allowing v and Fl,n, values to be expressed per unit
area of membrane for L:S comparisons. Surprisingly, ADP activation appeared to express all FbR within 1-3 s of ADP activation for
both L and S platelets, whereas k1 was similar for PMA activation. In addition, L platelets maximally expressed two and three times
more FbR per unit area than did S platelets when maximally stimulated, respectively, with ADP or PMA. Whereas k2 was
independent of platelet size for a given activator, the efficiency of PAC1 binding (a), per unit area of membrane, was two times
greater for L than for S platelets, for either ADP or PMA activation. Our data suggest that the FbR structure, its microenvironment, or
its surface organization may vary with platelet size or activator type. Major reorganization of FbR and/or its environment appears to
occur after 5 min of ADP activation equally for both L and S platelets. A model is presented to account for size-dependent
differences in FbR expression with implications for regulation of platelet aggregation.
INTRODUCTION
Human blood platelets show size-dependent heterogene-
ity in structure, biochemistry, and function (1-lla).
Studies have generally been conducted by physical
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'Abbreviations listed in this paper: ADP: adenosine diphosphate; AF:
autofluorescence values; C: control population; F:P:fluorescein:pro-
tein, ratio in molar; Fb, FbR: fibrinogen and receptor for Fb, respec-
tively; FITC-PAC1: fluorescein isothiocyanate-PAC1 antibody; Fl,
Fl1: mean fluorescence for a platelet population and maximal Fl at
equilibrium binding, respectively; Fn: fibronectin; FSC: forward scat-
ter; L: large platelets (- top 20%); M: medium platelets; PMA:
phorbol myristate acetate; PRP: platelet-rich plasma; RGD: arginine-
glycine-aspartate; S: small platelets (-bottom 20%); SAP: mean
geometric platelet surface area; SCCS: surface-connecting membrane;
SSC: side scatter; TA: dynamics of macroaggregation; VE, VP: mean
platelet volume determined electronically and microscopically, respec-
tively; VWF: von Willebrand factor.
separation of whole platelet populations into fractions
having differing mean volumes, with large variability in
the extent of overlap in size between fractions (<20%
[1-3] to >50% [4, 5]), and possible artifacts due to
isolation procedures (1-3). Studies of platelets sepa-
rated by counter flow centrifugation (elutriation) have
shown that large platelets are most responsive to aggre-
gating agents (1-3), contain highest concentrations of
dense and a-granules (2), are enzymatically most active
(2), appear most efficient in hemostatic effectiveness (6),
and may be distinctly produced from megakaryocytes of
low ploidy (7).
We recently evaluated size dependent differences in
platelet aggregation by comparing platelet suspensions
of different sized platelets obtained by elutriation, at
similar volume fractions in order to separate intrinsic
biochemical differences in platelets from simple physical
geometric differences. We reported that large (L)'
platelets were about twofold more sensitive and more
rapidly recruited into microaggregates in response to
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adenosine diphosphate (ADP) (5-100 ,uM) than were
small (S) platelets, when suspensions were compared at
identical volume fractions, i.e., at the same total surface
area of platelets (1, 8). We then suggested (1), as have
others (3, 9, 10), that these differences in size-dependent
subpopulations are intrinsic to the cells, and we pre-
dicted that large platelets will more readily and more
quickly transform GPIIb-IIIa surface molecules into
fibrinogen receptors (FbR) than will the small platelets,
at about twice the sensitivity and rate. We found that the
onset for platelet microaggregation induced by ADP
(5-100 ,uM) was < 0.5 s for L or S platelets, essentially as
for unfractionated platelet-rich plasma (PRP), with a
rapid linear increase in rate of microaggregation out to
> 4 s after ADP activation (1). We therefore required a
method for determining the expression of FbR within
seconds of platelet activation. In addition, the method
would ideally not require any physical separation of the
platelets from native PRP to minimize isolation artifacts
which are likely responsible for some of the controversy
in the relation between platelet size and function. For
example, Gear et al. (4, 5) have reported that large
platelets are more sensitive but slower responders to
ADP in aggregation than are small platelets, but they
used platelets separated functionally and by differential
centrifugation.
The method that best meets the above experimental
requirements is flow cytometry. We successfully used the
theoretical and experimental approach, developed in
Part I (lib), for measuring the dynamics of rapid
expression of the FbR on platelets activated with ADP
or phorbol myristate acetate (PMA) as a function of
platelet size; different-sized platelets are "electronically
gated" from the forward scatter properties (FSC) of the
whole platelet population. We determined, by direct
microscopy, the mean platelet volume and surface area
of L and S platelets physically separated with a cell
sorter selected by FSC. We could thus express fibrinogen
receptor (FbR) expression per unit area of membrane.
We then determined maximal on-rates (v.) and fluores-
cence (Flmu) for fluorescein isothiocyanate-PAC1 anti-
body (FITC-PAC1) binding to platelets activated with
ADP or PMA for L and S platelets. This allows a
comparison of rates of FbR expression (kI), and rates
(k2) and efficiencies (a) of binding of PAC1 to FbR as a
function of platelet size and activator. We found that L
platelets maximally express two and three times more
FbR per unit area than do S platelets in response to
ADP and PMA, respectively; however, maximal expres-
sion occurs within 1-3 s for ADP activation and at
comparable rates for PMA activation, independent of
platelet size. These FbR sites appear 2-10 times more
accessible to the PAC1 reporting probe depending on
activator type and platelet size. A model is proposed for
these differences.
METHODS
Platelet isolation and analysis by flow
cytometry
The procedures used are described in Part I (lib), with the data
derived from studies of six donors evaluated in Part I (llb) for both
PMA (0.2 p,M) and ADP (100 pIM) for FITC-PAC1 preparation one,
m. = 24 ,g/ml (F:P = 7.0).
Size-dependent subpopulations
To establish that forward scatter is a valid parameter to define
size-dependent platelet fractions, cell sorting was performed on a
FACS III (Becton-Dickinson Canada, Mississauga, Ontario) flow
cytometer for a glutaraldehyde-fixed platelet suspension. Cell sorter
gates were determined from a forward scatter histogram to obtain the
lower and upper 20% forward-scattering platelets (see Figs. 1 and
2A). These end fractions were collected from sorting and their mean
platelet volumes were determined from phase-contrast microscopy.
The mean size of the upper and lower forward scattering platelets
correspond to the smallest (S) and largest (L) platelets, respectively
(Fig. 2A). Subsequent size-dependent subpopulations (each - 20%
of the whole population) were analyzed by similar gating of forward
scatter histograms of whole populations after data acquisition with the
FACSTAR or FACSCAN, analytic instrument (Becton-Dickinson
Canada).
Size analysis of platelets
The fixed platelets sorted above were analyzed by phase-contrast
microscopy, using video recording and computer analyses, as previ-
ously described to measure individual platelet thickness (t), diameter
(d), from which were calculated the mean axial ratio (r,= tld),
geometric volume (Vp) and surface area (SA ), determined for at least
100 individual platelets (unactivated disc-shaped platelets) (11).
RESULTS
Correlation of platelet forward scatter
and geometric platelet size
To analyze the binding of FITC-PAC1 to platelets from
the fluorescence associated with different sized plate-
lets, we selected platelet size by obtaining FSC histo-
grams for a given PRP preparation, and then "gating" to
analytically select the 20% of platelets with the smallest
(S) or largest (L) FSC intensities, as shown in Fig. 1.
Although it is known that the FSC of biological
particles generally increases with the size of the particle
(12, 13), this parameter cannot be used as a measure of
actual platelet volume due to variable contributions
from particle shape, internal structure, and refractive
index (12-14). Because we also required a knowledge of
platelet surface area for L and S platelets, we deter-
mined the relationship of FSC to platelet geometric size
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FIGURE 1 Electronic gating of different sized platelets from forward scatter intensities. Unactivated human PRP, freshly fixed with
glutaraldehyde, was analyzed with a FACSTAR/sorter. InA the forward scatter (FSC) versus side scatter (SSC) cross-plot was obtained to identify
all platelets present outside the lower threshold noise and free of other blood cells (see Methods). Platelets with the smallest and largest FSC,
shown in the rectangles in A, were selected by setting gates on the FSC histogram shown in B, to represent the bottom and top 20% of forward
scattering particles (S and L, respectively).
directly for platelets physically separated with the cell
sorter. No platelets could be isolated by cell sorting in
the absence of fixation, presumably because unfixed
platelets cannot survive this isolation procedure. How-
ever, the FSC histograms were not significantly different
for fixed or unfixed PRP. There was no significant
change in the FSC or mean fluorescence (Fl) profiles of
these fixed platelets with cell sorting (Fig. 2). The Fl was
well above autofluorescence values for unfixed platelets
due to Fl induced by the glutaraldehyde fixation, which
was useful in providing a second parameter of platelet
size, similar to that previously reported by Holme et al.
(13). In fact, relative values for L and S platelets were
identical for both Fl and FSC parameters (ratio of 1.23),
as shown in Table 1. The geometric size was determined
for these "sorted" platelets by direct microscopy (Table
1). Three fractions were actually isolated by cell sorting,
and their Vp, determined for small (S), medium (M), and
large (L) platelets, were shown to be highly linearly
correlated with their mean FSC intensities, as well as
with mean fixative-induced Fl values (Fig. 3). We thus
certified that FSC, for normal platelet populations, does
correlate with platelet size and we could now express Fl
values per unit area of platelet for L versus S platelets.
However, we also needed to demonstrate that the
largest and smallest 20% of platelets could be "selected"
by "gating" FSC for platelets that had been activated
with ADP or PMA. We "selected" L, M, and S platelets
by "gating" for the 20% of fixed platelets with the
highest and lowest values of FSC or autofluorescence
(Fl), as well as for one third of all platelets yielding the
midrange values for the whole population. This was
done for the same donor's platelets for control or
activated with ADP or PMA. If the linear relation of
FSC or Fl with size shown in Fig. 3 for unactivated
platelets physically separated by size was equally valid
for activated platelets, then the "gating" for size by FSC
should also yield a linear correlation between FSC and
Fl, independent of activation, as shown in Fig. 4. Plots of
FSC or Fl versus Vp of the "resting" platelets (obtained
from Fig. 3) also gave linear correlations for L, M, and S
platelets (r = 0.95), independent of activation (curves
not shown). Finally, because we "select" L and S
platelets by "gating" on FSC for unfixed, activated
platelets, it is important to note that mean FSC values
increased by < 8 4% when comparing fixed platelets
with unfixed platelets, independently of activation or
platelet size.
The possible complications of platelet aggregation
were shown to be negligible in Part I (llb) (<5%
aggregation occurred in all cases). We reanalyzed mean
Fl values for ADP or PMA activated L platelets,
"selected" as particles with the top 15-20% of FSC
values after "gating" out the top 5% of FSC values, and
found < 20% decreases in Fl with such exclusion.
Distinct kinetics and extent of
FITC-PAC1 binding for L and S
platelets
The overall time course of specific FITC-PAC1 binding
to activated platelets was determined for PAC1 incuba-
tion times varying from 5 s out to 30 min by dilution
quenching PRP samples containing activator and PAC1
and obtaining fluorescence histograms for each of these
time points (reported in Part I [llb]). We then analyzed
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FIGURE 3 Platelet forward scatter is highly correlated with geometric
platelet volume. S, M, and L sized platelets were physically fraction-
ated with the FACS III (Becton-Dickinson Canada) cell sorter using
their FSC properties described in Fig. 2 and Table 1. The mean
geometric volume measured by direct microscopy for each of these
three fractions was plotted against the corresponding mean FSC or
mean autofluorescence, Fl (data in Table 1), giving a linear regression
plot (r = O.95,p < 0.05 for each of the two curves).
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FIGURE 2 Forward scatter and autofluorescence histograms of fixed
platelets before and after cell sorting. Using the electronic gating
procedure shown in Fig. 1, fixed platelets in PRP were analyzed for
(A) FSC and (B) autofluorescence (Fl) for the bottom 20% (S) and
top 20% (L) of particles analyzing FSC and Fl intensities histograms
independently, as well as the midfraction contain one-third of all
platelets (M).
these fluorescence histograms by plotting the Fl histo-
grams corresponding to the L and S platelets selected
from FSC profiles (Fig. 5). Fl values were thus deter-
mined for these L and S subpopulations, shown for one
donor's PRP in Fig. 5 which had been incubated with
100 ,uM ADP and FITC-PAC1 for 30 min. Platelets were
first maximally preactivated for a time T with PMA for 25
min or with ADP for 0-10 s. Fl time plots for such
preactivated platelets are shown for typical donors for
PMA (Fig. 6A) and for ADP (Fig. 6 B), where Fl values
are shown for the whole control population (C), as well
as for the L and S platelets. The initial increase in Fl
measured for t <15 s of PAC incubation yields the
maximal initial on-rates for PAC1 binding (vm.), as
described in Part I (11 b). It is seen that both S and L
platelets gave significant Fl values within 5 s of ADP
activation, with distinct values for vmax and for the
maximal increase in Fl by 30 min of PAC1 incubation,
FlmaxThese values for initial on-rates (vm.) and maximal
TABLE 1 Relation of platelet forward scatter (FSC) to platelet geometric size
Flow cytometry*
Platelet Flt FSC§ Microscopy geometry of sorted cells1l
subpopulation Pre Post Pre Post Volume Shape' Surface area
FU CN fl M2
Top 20% (L) 61 62 77 79 10.8 0.38 26.2
Bottom 20% (S) 50 50 64 62 6.6 0.35 19.4
L:S 1.22 1.24 1.20 1.27 1.64 1.09 1.35
*Flow cytometry values for Fl and FSC are reported for the fixed platelets analyzed pre- and postcell sorting, with histograms shown in Fig. 2
(FACS III [Becton-Dickinson Canada] cell sorter). The middle 33% of the population (M) had Fl, FSC, and V values of 56, 71, and 7.7 ,um3
respectively (pre or post); TF1 = mean Fl due to autofluorescence of GA fixed platelets, expressed in fluorescence units (FU); §log normal
distribution of FSC histograms where mean channel number (CN) is reported; Ilthe fixed cells were sorted according to their FSC profiles into a L
and S population and measured directly by microscopy (see Methods); 'the shape refers to the axial ratio, expressed as average rp, the ratio of
platelet thickness (t) to diameter (d).
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FIGURE 4 Platelet size "selected" by FSC correlates linearly with
autofluorescence for control, ADP or PMA-activated platelets. Plate-
lets were fixed for PRP control (circles), and for PRP maximally
preactivated with ADP (squares; 100 ,uM, r = 15 min) and PMA
(triangles; 0.2 ,uM, T = 45'). The large (0, *, A), medium (0, [3, A)
and small (0, O, A)-sized platelets were "selected" from the top 20%,
midfraction containing one-third of all platelets, and bottom 20%,
respectively. The mean FSC values and corresponding autofluores-
cence values (AF) were determined from the "selected" populations.
The FSC and AF were linearly correlated for control, ADP and PMA
samples (r = 0.99,p < 0.05).
binding (Flm.,c) are summarized in Table 2 for six donors,
each donor's PRP evaluated for both ADP and PMA
activation. It is seen that L platelets have both v.. and
Flm values which are three and four times greater than
those for small platelets, for ADP and PMA activation,
respectively. Part of this difference resides in the 1.4-
fold difference in surface area of L:S platelets (Table 1);
however, normalizing for this difference still yields a two
and three times greater vm, or Flmu values for L platelets
200
I~~~
FL I
FIGURE 5 Analysis ofFITC-PAC1 binding for size dependent subpop-
ulations by flow cytometry. Platelet-rich plasma was incubated with
100 pM ADP and FITC-PAC1 (added together for 30 min to yield
fluorescence) histogram (C) due to PACI bound to the maximally
activated platelets. By electronically gating for the top (L) and bottom
(S) 20% of forward scattering particles (Figs. 1 and 2), the correspond-
ing fluorescence histograms can then be obtained for these S and L
platelets, as shown.
than for S platelets, respectively, for ADP and PMA
activation.
As shown in Part I (lib), the ratios of vm. to Fl.,
values actually represent k2 values for on-rates of PAC1
to maximally preactivated platelets which are summa-
rized as relative values for L versus S platelets in Table 3
(k124k1). Thus, k2 appears approximately independent of
platelet size for both ADP and PMA activation, as is the
case of analyses of the rate of expression of FbR sites for
PMA (k, values [Table 3]). For ADP activation, k, was
> 20 min - 1 for both L and S platelets but actual ratios
could not be determined as maximal FbR expression
appears to occur in < 3 s for both L and S platelets.
However, the maximal numbers of PACl-binding sites
(Flmu) expressed per unit area of membrane are approx-
imately two and three times greater for ADP and PMA
activation, respectively.
We also obtained the relative efficiencies of L versus S
platelets (aL/aS) from the relative on-rates (vm. values in
Table 2) but corrected for differences in platelet size: we
found that maximally activated L platelets bound PAC1
about two times more efficiently than did S platelets, for
either ADP or PMA activation (Table 3).
We finally compared Flm.,., k2, and a values for ADP
versus PMA activation for the whole platelet population
as well as for L and S platelets, obtained for the same
platelet preparation from each of six donors (Table 4).
We found that whereas PMA causes approximately
twofold more PAC1 maximal expression for L platelets
than does ADP, there is only about a 1.4-fold increase in
Fla,c for the S platelets; the whole population shows
intermediate differences for PMA versus ADP (see Fl,.
ratios in Table 4). Although the rate constant for PAC1
binding to platelets maximally activated with PMA (k22)
was two to three times greater than for activation with
ADP for the large or total platelet population, it
appeared to be approximately four times greater for
activation of small platelets (relative k2 values in Table
4). This size-dependent difference was not apparent in
relative efficiencies, where PMA activation causes ap-
proximately fivefold greater increases in a than does
ADP activation, for L or S platelets.
Time dependent decay in v, after
activation with ADP
We reported in Part I (lib) that initial rates of increase
in Fl, (v), appeared to be maximal within 1-3 s of
ADP activation of platelets, but that v, values then
decayed by > 50% if platelets were preactivated for 15
min before addition of PAC1, with no significant change,
however, in Fl.,, values. These changes were ascribed to
changes in accessibility of the GPIIb-IIIa FbR to FITC-
PAC1 due to further conformational, microenvironmen-
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FIGURE 6 Dynamics of fibrinogen receptor expression on L versus S platelets for activation with (A) ADP and (B) PMA. Human PRP was
preactivated at times (T) yielding maximal initial rates of PACl-binding and maximal expression of PACl-binding sites (Table 2); this
corresponded to T = 1-10 s and 25 min for ADP and PMA, respectively. Activated PRP were then incubated for varying times r with FITC-PAC1,
dilution quenched and analyzed in the flow cytometer. The mean fluorescence (Fl) was then determined from fluorescence histograms for each
time point for the whole population (control C), as well as for the L and S platelets selected as the top and bottom 20% from FSC profiles (see Fig.
4). These plots of Fl versus PAC incubation time are shown for one representative donor for each activator.
tal or clustering effects, which could reduce v values
(on-rates) while not actually showing refractoriness or
disappearance of maximal numbers of FbR expressed
(Flm.). We found a similar "decay" ( - 30-40%) occur-
ring in initial on-rates (v) of PAC1 binding to activated
platelets after 5-15 min of activation with ADP for the
whole (total) population and for L or S platelets (Table
5). Moreover, Flm. was unchanged with time after ADP
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TABLE 2 Size-dependent differences in PACI binding kinetics
for maximal activation with PMA and ADP*
PMA ADP
Platelet
(0.2 FM; r = 25 min) (100 ,uM; X = 0-10 s)
subpopulation* Vmax Fl,,a, Vma Fl
FU/s FU FU/s FU
L 6.6 2.1 804 ± 231 1.5 ± 0.7 378 ± 94
S 2.0 0.7 196 ± 31 0.5 ± 0.2 141 ± 13
L:S1 3.5 ± 0.6 4.1 ± 0.9 3.2 ± 0.6 2.7 ± 0.6
L:SCOrrl 2.5 ±0.5 2.9 ± 0.6 2.3 ± 0.4 1.9 ± 0.4
*The mean ± SD is reported for pooled data for v.. and Fl., obtained
in parallel for PMA and ADP activation for each of six donors; T =
activation time of PRP before FITC-PAC1 addition; tL and S
represent large and small platelets selected from top and bottom 20%
of FSC values, as in Table 1; 'L:S ratios of v,,, and Fl,,,,, values were
determined for each donor and then averaged; icorrected by dividing
by 1.4, the ratio of mean surface area for L:S (see Table 1 and Results).
activation for L or S platelets. This "decay" in v, reflects
a comparable decrease in k2(T) and efficiency (a) (see
Eqs. 11-14 in Part I [llb]).
DISCUSSION
We have compared the rate and extent of binding of
FITC-PAC1 to its GPIIb-III, FbR on platelets activated
in PRP with ADP or PMA for large and small platelet
subpopulations. These have been "electronically" se-
lected from the FSC profiles of the unfixed platelets. We
demonstrated that FSC correlates well with geometric
platelet size (Vp) (Fig. 3) using fixed, unactivated,
disc-shaped platelets whose size and shape did not
change with the sorting procedure used for direct
TABLE 3 Relative dynamics for the expression and
occupancy of PACI binding sites for large versus small
platelets
L,/kis k2/k2s* FILFlm,s, I aL/asl
ADP 1.3 ± 0.3 1.9 0.4 2.1 + 0.3
PMA 1.06* 0.9 ± 0.2 2.9 ±0.6 2.1 ± 0.5
*kl was analyzed for one donor from Fig. 9 in Part I (lib) for the
second rapid phase seen with PMA activation with 0.2 FM; kiL/ks for
the initial slow phase (see Fig. 9 in Part I [llb]) = 0.8, but kiLk1 for the
whole population = 1.0, with uncertainty in ks due to very low
fluorescence values at early activation times; %k2 values were obtained
from the six donors in Table 2; k2m. values for L platelets were
respectively 0.24 ± 0.07 and 0.60 ± 0.18 min-' for ADP and PMA
activation; 'corrected for surface area differences (from Table 2);
Irelative efficiencies equal column 2 x column 3 divided by aLl/as1 =
1.18 for V"3 taken from Fig. 3 for resting platelets using Eqs. 12 and 13
from Part I (lib); aL for PMA and ADP is typically -20 and 4%,
respectively.
TABLE 4 Comparison of Fl,.,,,, k2, and a for PAC1 sites
Induced by PMA versus ADP for total platelets, for large and
for small platelets
Ratios of values for PMA:ADP for*
Platelet Flmax(PMA)/ k2(PMA)/ ao(PMA)/
size' Fl..,(ADP) k2(ADP) ox(ADP)
Total cells 1.8 ± 0.6 1.7 ± 0.3 3.0 ± 0.6
L 2.2 0.7 2.7 ± 1.7 5.3 2.9
S 1.4±0.2 3.9+2.8 5.2±3.2
L:S* 1.61 0.721 1.1 (NS)'
*Six donors with PMA and ADP activation studied in parallel. Ratios
for Fl.. (PMA)/Fl.. (ADP), as well as for k2 and a values, were
determined for each donor, and mean ± SD reported; *data are
reported for the total population from Table 2 in Part I (lib) for the
same six donors; 'values of L to S platelets (L:S) were obtained for
each donor and the mean ratio determined for all six donors;
significance of differences were evaluated with a one-tailed paired
t-test: Np < 0.05; 'p > 0.10. A similar comparison of total cells: L
platelets showedp < 0.05, > 0.1, and < 0.1, respectively, for Flma., k2,
and a ratios.
microscopic determinations of size (Fig. 2 and Table 1).
This direct linear correlation of FSC and Vp is consistent
with another report which demonstrated a highly signifi-
cant linear correlation between FSC and mean elec-
tronic size VE obtained for parallel samples of unfixed
whole PRP for different normal human donors (13). We
additionally demonstrated that FSC and fixative-
induced autofluorescence both correlated linearly with
size for physically sorted unactivated fixed platelets (Fig.
3), as well as for platelets maximally activated with ADP
or PMA which were "selected" for size from FSC
"gating" (Fig. 4). We could now compare the mean
fluorescence, Fl, for L and S platelets by simple com-
puter-driven selection of Fl values corresponding to
selected FSC values (Fig. 5). This permitted a compari-
son of rates (v) and extent (Flm,,) of FITC-PAC1
binding to activated platelets as a function of platelet
size for both PMA (Fig. 6A) and ADP (Fig. 6 B). As
large platelets showed three to fourfold greater values
for either vmax or Flma compared to small platelets when
maximally preactivated with either ADP or PMA (Table
2), we wished to dissociate these differences from simple
physical differences due to surface area.
We found for the one donor's platelets isolated by cell
sorting that the large platelets (as selected from 20% of
platelets with the largest FSC) had a geometric surface
area, SAp, which was 1.35 x that of S platelets. To
normalize Fl values for L and S platelets for different
donors, we chose an SAp ratio of 1.4 for L:S (Table 2).
This was determined as follows. We have previously
demonstrated that mean electronic volumes (VE) for L
and S platelets separated by elutriation as top and
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TAsLE 5 Time-dependent decay in v, for ADP-induced activation
vTt Fl, ,at
Preincubation
time (O)* Total L S Total L S
FU/s FU
1-3 s 1.0 1.0 1.0 1.0 1.0 1.0
5-15 min 0.69 + 0.24' 0.71 ± 0.22 0.61 ± 0.28 1.0 ± 0.05 0.99 ± 0.02 0.95 ± 0.07
*Platelets were activated in PRP (1:10) with 100 F.M ADP for different times r preceding addition ofFITC-PAC1, for three donors; tinitial rates of
Fl increase were measured for different T values (vU), as well as Fl,,., values measured for PAC1 incubation for > 30 min (see Fig. 5 and Part I
[1 lb]); 'values in this row were expressed as a fraction of the values obtained for T = 1-35.
bottom 16-20% of the population, remained relatively
constant for different donors (n = 11) (1): in fact VE(L):
VE(S) = 1.7 + 0.2 (n = 11). The relative surface area
values for equivalent spheres becomes V3(L):VI (5) =
1.4 + 0.1. It is known that Vp(L):Vp(S) = VE(L):VE(S)
for platelets having the same shape (15) and it therefore
follows that [VP(L):V,(S)]f = 1.4 + 0.1 (n = 11)]. Fi-
nally, it can be calculated from Table 2 that [Vp(L):
Vp (S)]' = 1.39, comparable to the value obtained from
direct measures of SAp(L):SA4P(S) = 1.35. Relative
surface areas can thus be determined simply from
electronically-derived VE values. In the case of normal
donors, a mean value of 1.4 + 0.1 can confidently be
used for L:S values of SAp, especially in our studies
where the five donors evaluated were chosen from this
same pool of donors used for our previous report (1).
The above comparison of relative surface areas for
unactivated, smooth-surfaced L and S platelets will
equally be valid for activated platelets if the following
conditions are satisfied: the membrane roughening and
surface projections occurring with platelet activation (9,
16) do not alter the amount of membrane and associated
number ofFbR accessible to the reporting probe (FITC-
PAC1), or any such changes occur equally for L and S
platelets. The FITC-PAC1 reporting molecule is an IgM
expected to penetrate the surface-connecting membrane
(SCCS) reported to have pore sizes of -500-2,000 A
(9). Therefore, the reported increases in mean surface
area (- 25%) occurring with platelet activation, likely
associated with outflow of SCCS (9, 16), are not ex-
pected to affect total Fl measured for L or S platelets; it
must be noted in this regard that a constant twofold
increase in external surface area occurs with hypo-
osmotic externalization of all SCCS for L or S platelets
(17). Although it appears unlikely, we cannot presently
rule out the possibility that L platelets selectively exter-
nalize or render accessible more SCCS (or other internal
membrane pools) and associated FbR than do S plate-
lets upon ADP and PMA activation. In such a case, the
surface density of FbR for L platelets would be closer to
that for S platelets only if L platelets externalized all of
their SCCS.
Large platelets appear to maximally express about two
times more FbR per unit area of membrane than do the
small platelets when activated with ADP (Table 3), but
somewhat surprisingly, ADP activation appears to ex-
press all FbR within 1-3 s irrespective of platelet size,
i.e., equivalent vm. was observed for T = 0, 1, 2, or 3 s for
L or S platelets when analyzed as described in Part I
(llb) (data not shown). Thus, the actual rate of FbR
expression may be 10,000 FbR/s, all expressed within 1 s
for both L and S platelets (taking 10,000 as an average
number of maximal FbR expressed with ADP [18, 19]).
This result is fully consistent with our previous report (1)
that the onset for platelet aggregation is < 0.5 s for L or
S platelets but appears in conflict with the greater than
twofold slower rate of aggregation of S platelets mea-
sured between 2-10 s after ADP addition (Fig. 1 in
reference 1). It therefore appears that the FbR density
or number per unit area may regulate the rate of platelet
aggregation in the early aggregation phase (within the
first few seconds of activation), rather than the rate of
expression of FbR. It is additionally possible that the
surface density and accessibility of FbR, which are also
affected by post-Fb binding events (18), may be rate-
determining in platelet aggregation, rather than the
number of FbR per se, because these appear maximally
expressed well before aggregation is complete. In this
regard, it is important to note that the efficiency of
PAC1 binding (a) to ADP-activated platelets was two
times greater for L than for S platelets (Table 3),
suggesting that the surface distribution and accessibility
of FbR to PAC1 favor more efficient binding of PAC1 to
its specific receptor on L platelets compared to S
platelets once all are maximally expressed: this may
reflect important structural differences in FbR and its
microenvironment which favor "functional" expression
of FbR-adhesive proteins. Finally, it would appear that
these differences in FbR expression and organization for
L versus S platelets are unrelated to the dynamics of
macroaggregation (TA) insofar as TA was shown to be
independent of platelet size when adjusted for surface
area differences (1).
Although L platelets appear to express approximately
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two to three times more PAC1 binding sites per unit
area of platelet surface membrane than do S platelets
after activation with ADP or PMA, the efficiencies of
PAC1 binding are approximately twofold greater for L
than for S platelets, for either activator (Table 3). This is
not reflected in relative rate constants for PAC1 binding
(k2), which are independent of platelet surface area and
appear independent of platelet size for a given activator
(Table 3).
As predicted for ADP, PMA activation appears to
express new FbR sites at a comparable rate for L and S
platelets (relative k, values in Table 3). However, L
platelets express approximately three times more maxi-
mal numbers of FbR sites than do S platelets (relative
FlM values in Table 3). Because PMA activation causes
externalization of a-granule membranes and additional
GPIIb-IIa from the intracellular pool (18, 20), it is
possible that FbR expression is also a function of
platelet secretion. The report that rates of secretion are
similar for L and S platelets isolated by elutriation (2)
are consistent with our observation that k1 for FbR are
comparable; but we found that the final extent of FbR
expression differ. Moreover, maximal FbR expression
was twofold greater for L than for S platelets for ADP
activation, where negligible secretion is expected (no
significant platelet aggregation in our experimental con-
ditions). In this regard, it is seen that PMA causes 2.2
times greater maximal expression of FbR on L platelets
than does ADP, with 40% lower relative effect on S
platelets (Table 4). This may reflect L platelets recruit-
ing more FbR from internal pools (18, 20).
In addition, L platelets may be more efficient at
converting the inactive GPIIb-IIIa to its FbR form, i.e., a
greater percent of all GPIIb-IIIa are transformed for L
platelets than for S platelets, as reflected in the above.
However the efficiency of conversion of GPIIb-IIIa to
FbR also requires a knowledge of the surface density of
all GPIIb-IIIa molecules (inactive and FbR forms) which
we are measuring with other appropriate antibodies,
such as FITC-labeled AP-2 (21) and Tab (22). Our
preliminary results with AP-2 and Tab suggest that
surface densities of GPIIb-IIIa on resting platelets are
identical for unactivated L and S platelets, but effects of
activators and of secretion of internal FbR pools must be
evaluated.
The relative efficiency of PAC1 capture by PMA-
activated platelets (a) is approximately five times greater
than for ADP-activated platelets, whether comparing L
or S platelets (compare vma. ratios for PMA:ADP in
Table 2 and see relative at values in Table 4). Finally,
either ADP or PMA-activated platelets had a values two
times greater for L versus S platelets (Table 3). Thus,
both platelet size and activator type can enhance the
capture efficiency of FbR for PAC1 by up to 10-fold.
This reflects altered FbR structure/microenvironment/
surface organization favoring capture efficiency of the
PAC1 molecule. It is expected that similar observations
will be found with other arginine-glycine-aspartate
(RGD)-containing adhesive proteins, including Fb, VWF
(von Willebrand factor), and Fn (fibronectin).
The apparent decay in rates of binding of PAC1 to
platelets preactivated with ADP at longer activation
times (t > 5 min), compared to short activation times
(T 1-3 s) (Table 5), suggests that changes occur in the
microenvironment or in the organization of FbR in the
activated platelet surface with increasing activation
time. Identical apparent changes were seen in vT for L
and S platelets, with no decay in Flma. values. This
- 30-40% decay in vT thus corresponds to a comparable
decay in both k2 and the efficiency of PAC1 binding (a)
(see Eq. 14 in Part I [llb]), suggesting that similar
reorganization occurs with activation time independent
of platelet size. If the poorer accessibility to these FbR
by PAC1 is also reflected in fibrinogen binding, we
would predict that initial rates of platelet aggregation
would decrease with increasing times of preincubation
with ADP. However, microaggregation has been shown
to be independent of X values (23). Moreover, these
differences in vT and Flma appear irrelevant to L platelet
aggregate build-up measured turbidimetrically (TA), as
L and S platelets have been reported to yield compara-
ble macroaggregation when corrected for effects of size
(1).
The regulation of platelet aggregation and the role of
the fibrinogen receptor in this regulation will be better
characterized through parallel measures of platelet size,
membrane rearrangements, and changes in the total
number of GPIIb-IIIa molecules and active Fb receptors
as a function of pre- and post-Fb binding. This is being
done with flow cytometry using appropriately selected
fluorescently labeled antibodies such as S12 (24) to
follow a-granule secretion.
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